How have TOIIW shares performed in 2024?

Oncology Institute's stock was trading at $0.20 at the beginning of 2024. Since then, TOIIW shares have increased by 12.8% and is now trading at $0.2255. View the best growth stocks for 2024 here .

How do I buy shares of Oncology Institute?

Shares of TOIIW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:TOIIW

Oncology Institute (TOIIW) Stock Price, News & Analysis

→ The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad)

Free TOIIW Stock Alerts

$0.23

0.00 (0.00%)

(As of 04/24/2024 ET)

Compare

Today's Range: $0.23
▼
$0.23
50-Day Range: $0.18
▼
$0.30
52-Week Range: $0.02
▼
$0.37

Volume: N/A
Average Volume: 10,481 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Financials Insider Trades Ownership SEC Filings Short Interest Social Media

Get Oncology Institute alerts:

Ad Crypto Swap Profits

He Is Giving Away Bitcoin

And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

>> Register right here

About Oncology Institute Stock (NASDAQ:TOIIW)

The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.

TOIIW Stock Price History

30 days | 90 days | 365 days | Advanced Chart

TOIIW Stock News Headlines

March 27, 2024 | investorplace.com

TOI Stock Earnings: The Oncology Institute Misses EPS, Beats Revenue for Q4 2023

See More Headlines

Receive TOIIW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oncology Institute and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Medical Care Facilities
Sub-Industry: N/A
Current Symbol: NASDAQ:TOIIW
CUSIP: N/A
CIK: 1799191
Web: www.theoncologyinstitute.com
Phone: 213 760 1328
Fax: N/A
Employees: 800
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: $324.24 million
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Beginner's Guide to Pot Stock Investing

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

Mr. Richard Alan Barasch (Age 70)
Executive Chairman of the Board
Dr. Daniel Virnich FACHE (Age 45)
M.D., MBA, Chief Executive Officer
Comp: $606.08k
Mr. Mihir Arunkumar Shah CPA (Age 46)
Chief Financial Officer & Principal Accounting Officer
Comp: $393.65k
Ms. Hilda Agajanian M.B.A.
Founder & Chief Growth Officer
Dr. Richy Agajanian M.D.
Founder & Chief Clinical Officer
Mr. Jeremy N. Castle M.B.A. (Age 40)
Chief Operations Officer
Mr. Rakesh Singh M.B.A.
Director of Technology
Mr. Mark Hueppelsheuser Esq.
General Counsel
Mr. Khurrum Shah J.D.
M.B.A., Senior Vice President of Compliance
Ms. Julie Korinke
Director of Marketing & Communications

Key Competitors

View All Competitors

TOIIW Stock Analysis - Frequently Asked Questions

How have TOIIW shares performed in 2024?: Oncology Institute's stock was trading at $0.20 at the beginning of 2024. Since then, TOIIW shares have increased by 12.8% and is now trading at $0.2255.
View the best growth stocks for 2024 here.
How do I buy shares of Oncology Institute?: Shares of TOIIW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:TOIIW) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial